Colibri’s transcatheter aortic valve [TAVR] EU pilot study validates its pre-mounted, pre-packaged, dry tissue, ready-to-use balloon-expanded valve with demonstration of superior hemodynamics

LOUISVILLE, Colo., Dec. 1, 2023 /PRNewswire/ — The initial findings of Colibri Heart Valve’s multicenter high-risk TAVR EU pilot study were presented at PCR London Valves November 20th, 2023. The study was conducted by CERC (Centre Européen de Recherche Cardiovasculaire) as acting CRO…